The overexpression of oncogene products also contributes to paclitaxel resistance, among which the transcription factor signal transducer and activator of transcription 3 (STAT3) is frequently overexpressed and activated in paclitaxel-resistant breast cancer and is associated with tubulin [6]. The gene discussed is STAT3; the disease is breast cancer.